Get the Stockscreener App
0.159
3.05%
-0.005
Pre-market:
.15
-0.009
-5.66%
Glucotrack Inc stock is traded at $0.159, with a volume of 1.01M.
It is down -3.05% in the last 24 hours and down -57.26% over the past month.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
See More
Previous Close:
$0.164
Open:
$0.157
24h Volume:
1.01M
Relative Volume:
0.19
Market Cap:
$2.24M
Revenue:
-
Net Income/Loss:
$-8.74M
P/E Ratio:
-0.0776
EPS:
-2.05
Net Cash Flow:
$-8.25M
1W Performance:
-6.47%
1M Performance:
-57.26%
6M Performance:
-99.63%
1Y Performance:
-99.78%
1-Day Range:
$0.15
$0.167
1-Week Range:
$0.15
$0.178
52-Week Range:
$0.1313
$99.00
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.159 | 2.24M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Glucotrack Inc Stock (GCTK) Latest News
GlucoTrack Joins EU Bionic Pancreas Initiative - TipRanks
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - The Manila Times
Major Breakthrough: Glucotrack Selected for EU's Revolutionary Bionic Pancreas Project - Stock Titan
GCTK stock plunges to 52-week low of $0.15 amid market turmoil By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low of $0.15 amid market turmoil - Investing.com India
Glucotrack faces Nasdaq delisting over share price rule - Investing.com Australia
Glucotrack faces Nasdaq delisting over share price rule By Investing.com - Investing.com South Africa
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis By Investing.com - Investing.com South Africa
6 Alternatives to Apple’s Non-Invasive Glucose Monitoring You Can Try Now - The Mac Observer
GlucoTrack Partners with OneTwo Analytics for AI-Driven Insights - TipRanks
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis - Investing.com Australia
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewswire
Game-Changing Implantable Glucose Monitor Partners With AI Firm for 3-Year Clinical Study - Stock Titan
Glucotrack Reports Transformative Year with Clinical Advances - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
GlucoTrack Advances with Clinical Trials and Funding Boost - TipRanks
Glucotrack, Inc. SEC 10-K Report - TradingView
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - The Manila Times
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week - MSN
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence - Investing.com India
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
GlucoTrack Inc (NASDAQ: GCTK) Analysts Prediction On How Much It Could Rise - Stocks Register
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last - Asianet Newsable
Why Did GlucoTrack Plunge 15.72%? - AInvest
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack to Present at TechBio Showcase™ 2025 - The Globe and Mail
GCTK stock plunges to 52-week low, touches $0.31 By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
GCTK stock plunges to 52-week low, touches $0.31 - Investing.com
Pre-market Movers: IBO, ALUR, GCTK, TELA... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack to present breakthrough blood glucose monitoring data at conference - ROI-NJ.com
Glucotrack To Present First-In-Human Results Of Continuous Blood Glucose Monitor At ATTD 2025 - Nasdaq
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care - Nasdaq
GlucoTrack to Present Data on New Glucose Monitoring System - TipRanks
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes - The Manila Times
Glucotrack, Inc. Announces First-in-Human Trial Data for Continuous Blood Glucose Monitoring System to be Presented at 2025 ATTD Conference - Nasdaq
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):